UK scientists developing Ebola vaccine that could be ready for trials in months
The rare species of Ebola involved – known as Bundibugyo – kills around a third of those infected and has no proven vaccine yet.
another news portal
The rare species of Ebola involved – known as Bundibugyo – kills around a third of those infected and has no proven vaccine yet.
Researchers found that more than half of urban rats sampled from low-income communities in Salvador, Brazil, carried active pharmaceutical ingredients in their brain tissue. These
AI-driven genomic analysis could help researchers identify existing drugs that may be repurposed for subtype-specific breast cancer treatment. The review proposes an interpretability-driven framework that
Why are conditions such as chronic stress, depression, cardiovascular disease, fragmented sleep, and aging all associated with a higher risk of dementia? In a new
Hair, nails, and horns, all made up of keratin, are some of the hardest and most resilient structures in animals. Inside zebrafish cells, keratin plays
When it comes to cancer, tumor suppressor genes are usually thought of as the “good guys.” These genes make proteins that protect and repair DNA
Bereaved families are calling for a national cardiac screening programme for over-14s
Locked down Americans sound off on Jay Bhattacharya: “It’s a violation of trust” and “They are acting in bad faith. The post I Wasn’t Worried
There’s a lot less than meets the eye to a recent Cochrane review that casts doubt on the efficacy of drugs for Alzheimer’s disease. The
U.S. Customs and Border Protection said an Air France flight bound for Detroit was diverted to Montreal after a passenger from the Congo boarded “in
The number of melanoma skin cancer cases has risen above 20,000 a year for the first time in the UK.
Head spas, which offer scalp and face massages, are gaining popularity in the U.S. Hundreds of locations, especially in California and New York, now offer
A new research paper was published in Volume 13 of Oncoscience on April 2, 2026, titled “Selective blood–brain barrier penetration and tumor targeting of nitrosylcobalamin
In an unexpected finding, a new study flips on its head researchers’ understanding of how precancerous pancreas lesions evolve into pancreatic cancer.